Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Toshiaki Okada"'
Autor:
Masatoshi Maki, Ryo Takada, Akihiko Taniguchi, Naoyuki Nomura, Seiichiro Kuramoto, Yuki Chiko, Toshiaki Okada, Seiji Saito, Koji Tamura
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Background COVID-19 has become a significant health threat and a primary healthcare concern among the most vulnerable patients with cancer. Patients with COVID-19 who have lung cancer are at great risk and need careful monitoring if they are
Externí odkaz:
https://doaj.org/article/04fdeab9db774fafa447bd5bbde9694a
Autor:
Patlada Suthamwong, Manabu Minami, Toshiaki Okada, Nonomi Shiwaku, Mai Uesugi, Masayuki Yokode, Kaeko Kamei
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Type 2 diabetes mellitus is characterized by insulin resistance and pancreatic β-cell dysfunction. A decrease in β-cell mass, which occurs during the progression of Type 2 diabetes mellitus, contributes to impaired insulin secre
Externí odkaz:
https://doaj.org/article/12fb102d741b41e9ac1e43c903051cba
Autor:
Md. Rafiqul Islam, Toshiaki Okada, Petr G. Merzlyak, Abduqodir H. Toychiev, Yuhko Ando-Akatsuka, Ravshan Z. Sabirov, Yasonobu Okada
Publikováno v:
Cellular Physiology and Biochemistry, Vol 54, Iss 1, Pp 538-555 (2020)
Externí odkaz:
https://doaj.org/article/133a9d4b03334813b995eaa422f58467
Autor:
Naohiro Oda, Keiji Miyoshi, Daisuke Morichika, Yuka Beika, Takahiro Taki, Reo Mitani, Toshiaki Okada, Ichiro Takata
Publikováno v:
Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Abstract COVID‐19 in cancer patients on immunosuppressive agents for the treatment of immune‐related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesi
Externí odkaz:
https://doaj.org/article/e1cf2529d28f48dfb3f0dab67d7fb366
Autor:
Ravshan Z. Sabirov, Md. Rafiqul Islam, Toshiaki Okada, Petr G. Merzlyak, Ranokhon S. Kurbannazarova, Nargiza A. Tsiferova, Yasunobu Okada
Publikováno v:
Life, Vol 11, Iss 6, p 509 (2021)
The Maxi-Cl phenotype accounts for the majority (app. 60%) of reports on the large-conductance maxi-anion channels (MACs) and has been detected in almost every type of cell, including placenta, endothelium, lymphocyte, cardiac myocyte, neuron, and gl
Externí odkaz:
https://doaj.org/article/676e9c218a9546b8884e02e28e202874
Publikováno v:
Cellular Physiology and Biochemistry, Vol 33, Iss 3, Pp 539-556 (2014)
Background: ClC-3, a member of the ClC family, is predicted to have six isoforms, ClC-3a to -3f, with distinct N- and C-terminal amino acid sequences. There have been conflicting reports on the properties of ClC-3a (also known as the N-terminal short
Externí odkaz:
https://doaj.org/article/d82e4b93822547df97dde0b4eddfc2f0
Autor:
Yuki Chiko, Yuka Sugisaki, Keiji Miyoshi, Daisuke Morichika, Yuka Beika, Akihiko Taniguchi, Eiki Ichihara, Toshiaki Okada
Publikováno v:
Internal Medicine. 62:881-884
Autor:
Yuki, Chiko, Yuka, Sugisaki, Keiji, Miyoshi, Daisuke, Morichika, Yuka, Beika, Akihiko, Taniguchi, Eiki, Ichihara, Toshiaki, Okada
Publikováno v:
Internal medicine (Tokyo, Japan).
A 72-year-old woman with opsoclonus visited our hospital and was diagnosed with small-cell lung cancer. Blood tests revealed anti-SOX1 antibodies, so the patient was diagnosed with paraneoplastic opsoclonus-myoclonus syndrome. After steroid pulse the
Publikováno v:
Venoms and Toxins. 2
Abstract: Ion channel function is essential for maintaining life and is involved in various physiological activities. However, various factors such as heredity, aging, wounding, and diseases can cause abnormalities in ion channel function and express
Autor:
Yuhko Ando-Akatsuka, Toshiaki Okada, Rafiqul Islam, Abduqodir Toychiev, Petr G. Merzlyak, Yasunobu Okada, Ravshan Z. Sabirov
Publikováno v:
Cellular Physiology and Biochemistry. 54:538-555
BACKGROUND/AIMS Maxi-anion channel (Maxi-Cl) is ubiquitously expressed and involved in a number of important cell functions especially by serving as an ATP release pathway. We recently identified SLCO2A1 as its essential core component. However, the